Related Experiment Video
Updated: Jul 16, 2026
10:49
Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
Cell transplantation for Huntington's disease Should we continue?
Stephen B Dunnett1, Anne E Rosser
1Cardiff University, Cardiff, Wales, UK. dunnett@cf.ac.uk
Brain Research Bulletin
|March 14, 2007
Summary
Cell transplantation for Huntington's disease is feasible and safe in early trials, but efficacy evidence is limited. Further research and refinement of protocols are needed to realize its therapeutic potential.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Biology
Background:
- Huntington's disease is a neurodegenerative disorder.
- Cell transplantation has emerged as a potential therapeutic strategy.
- Pilot clinical trials have been conducted in the USA, France, and the UK.
Purpose of the Study:
- To review the background of striatal cell transplantation in Huntington's disease models.
- To examine the rationale for human application.
- To survey the current status of preliminary patient studies.
Main Methods:
- Review of experimental animal models.
- Analysis of preliminary human clinical trial data.
- Identification of key parameters requiring refinement.
Main Results:
- Cell transplantation procedures are feasible and safe under specific conditions.
- Evidence for clinical efficacy remains limited.
- Several critical parameters require further definition and optimization.
Conclusions:
- Despite limited current efficacy, cell transplantation holds significant therapeutic potential for Huntington's disease.
- Continued investigation and experimental refinement of protocols are warranted.
- Cell transplantation remains a promising strategy for future Huntington's disease treatment.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...